NL-OMON50706招募中不适用
A multicenter study for validation of biomarkers and observational study for immune regulatory mechanisms in Juvenile Dermatomyositis - Biomarkers and immunoregulatory mechanisms in JDM
niversitair Medisch Centrum Utrecht0 个研究点目标入组 365 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 365
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •- consenting to participate
- •- diagnosis of JDM according to Bohan and Peter criteria and/or EULAR/ACR
- •classification criteria.
- •- age < 18 years
- •S4S disease controls:
- •- consenting to participate
- •- age < 18 years
- •- diagnosis of congenital myopathy, muscular dystrophy or mitochondrial
- •myopathy or other non-inflammatory myopathies or neuromuscular diseases
- •- Consenting to participate
- •- Definite IIM according to EULAR/ACR classification criteria
- •- Myositis overlap syndromes
- •- Age >=18 yrs
- •Systemic autoimmune diseases:
- •- Diagnosis of systemic lupus erythematodes (SLE), mixed connective tissue
- •disease (MCTD), overlap syndromes, scleroderma/morphea, vasculitis, or other
- •systemic autoimmune disease
- •Healthy controls:
- •- Consenting to participate
- •- Age <18 years
排除标准
- •In all groups: no informed consent
- •S4S disease controls: chronic inflammatory diseases
- •Healthy controls: immune-mediated, neurological or metabolic diseases
研究者
相似试验
已完成
不适用
A Multicenter Study on Biomarker Development Utilizing AI Multiomics for Patients with Advanced Solid Malignant TumorsAdvanced Solid MalignanciesJPRN-UMIN000043899ational Cancer Center Hospital East2,768
招募中
不适用
A single arm multicenter biomarker study determining the response to taxane-based chemotherapy in metastatic breast cancer patients with ESR1 mutations in cellfree DNAbreast cancer, metastasis, ESR1 mutations, chemotherapyNL-OMON25511Erasmus MC Cancer Institute, department of Medical Oncology185
招募中
不适用
A single arm multicenter biomarker study determining the response to taxane-based chemotherapy in metastatic breast cancer (MBC) patients with ESR1 mutations in cell-free DNA: TAX-ESR1 study.Metastasis of breast cancer10006291NL-OMON46354Erasmus MC, Universitair Medisch Centrum Rotterdam175
已完成
不适用
Study on biomarkers for the effect and safety of the treatment with Atezolizumab + Bevacizumab for liver cancerunresectable advanced hepatocellular carcinomaJPRN-UMIN000047758agoya University Graduate School of Medicine99
招募中
Unknown
METBEIGE biomarker studycolorectal cancerJPRN-jRCT1080224637ational Cancer Center Hospital East54